U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07654348) titled 'Efficacy and Mechanism of IPSRT for Bipolar II Disorder' on June 12.
Brief Summary: This project is based on the biphasic instability model and social timing theory, utilizing IPSRT to help regulate social interactions and establish regular daily habits, alleviate emotional symptoms, and prevent. The included patients with bipolar II disorder who did not take medication for the first time or relapsed within the past month were randomly divided into a medication only group (Q group), a only IPSRT group (I group). Group Q received treatment with quetiapine alone (starting at 50mg/day, with an additional 50mg to 300mg/day per week, and...